XM does not provide services to residents of the United States of America.
C
C

Church&Dwight

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Cheesecake Factory, Netflix, Texas Roadhouse

U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse April 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cheesecake Factory, Netflix and Texas Roadhouse, on Friday. HIGHLIGHTS * Cheesecake Factory Inc CAKE.O : Stephens resumes coverage with overweight rating * Corteva Inc CTVA.N : JP Morgan cuts to neutral from overweight * Gitlab Inc GTLB.O : Raymond James raises to outperform from market perform
A
A
B
B
C
C
C
F
M
N
R
W
A
A
A
C
C
C
D

U.S. Aerovironment, Hubspot, Uber Technologies

U.S. RESEARCH ROUNDUP-Aerovironment, Hubspot, Uber Technologies April 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies including Aerovironment, Hubspot and Uber Technologies, on Friday. HIGHLIGHTS * Aerovironment Inc AVAV.O : RBC raises target price to $165 from $160 * First Horizon Corp FHN.N : KBW raises to outperform from market perform * Hubspot Inc HUBS.N : Scotiabank raises target price to $700 from $650 * Sofi Technologi
C
T
E
G
U
A
C
C
L

U.S. Duolingo, Mid-America Apartment Communities, Nextracker

U.S. RESEARCH ROUNDUP-Duolingo, Mid-America Apartment Communities, Nextracker March 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Duolingo, Mid-America Apartment Communities and Nextracker on Monday. HIGHLIGHTS * Duolingo Inc DUOL.O : JP Morgan initiates coverage with overweight rating; PT $270 * Mid-America Apartment Communities Inc MAA.N : Jefferies cuts PT to $135 from $136 * Nexpoint Residential Trust Inc NX
A
B
C
D
V
A
A
L
F
C
D
I

U.S. Crown Holdings, Waters, West Pharmaceutical Service

U.S. RESEARCH ROUNDUP-Crown Holdings, Waters, West Pharmaceutical Service Feb 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Crown Holdings, Waters and West Pharmaceutical Service, on Wednesday. HIGHLIGHTS * Chipotle Mexican Grill Inc CMG.N : TD Cowen raises target price to $2,900 from $2,650 * Crown Holdings Inc CCK.N : JP Morgan raises to overweight from neutral * Palantir Technologies Inc PLTR.N : Jefferies rais
A
A
B
C
C
C
C
F
G
A
C
W
A
A
A
C
C

U.S. Apellis Pharmaceuticals, Saia, Tesla

U.S. RESEARCH ROUNDUP-Apellis Pharmaceuticals, Saia, Tesla Feb 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apellis Pharmaceuticals, Saia and Tesla, on Monday. HIGHLIGHTS * Apellis Pharmaceuticals Inc APLS.O : Jefferies raises to buy from hold * Charter Communications Inc CHTR.O : JP Morgan cuts to neutral from overweight * Lancaster Colony Corp LANC.O : Stephens cuts to equal weight from overweight * Saia Inc SA
A
B
B
C
C
C
P
R
T
W
C
C
C
C
C
D
E

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.